No Wasted Space Act

The No Wasted Space Act (HR8810), introduced on May 14, 2026 by Rep. Carey (R-OH), proposes creating a commission to study new uses for the Smithsonian's Arts and Industries Building on the National Mall. The commission would consist of 9 voting members appointed by congressional leaders and the Smithsonian Board of Regents, tasked with reporting to the President and Congress within one year of its first meeting. The bill explicitly prohibits federal employees from serving on the commission. There is no authorized or appropriated funding in the bill text. The legislation is purely procedural — it creates a study body but does not allocate any money for construction, renovation, operations, or contracts. Any future spending would require a separate appropriations bill, which has not been introduced. The bill has been referred to three committees (House Administration, Transportation and Infrastructure, Natural Resources) — the earliest stage of the legislative process. It has one cosponsor. No companion bill exists in the Senate. The legislative path is long and uncertain; most study commissions at this stage never advance to law. No publicly traded company is directly mentioned or affected by this bill. The study of a single historic building on the National Mall does not create revenue opportunities for infrastructure, construction, engineering, or tourism companies. Commission members are appointed, not contracted. There are no tax credits, mandates, regulatory changes, or procurement provisions in the text. Based on the provided financial data, companies such as $CSX, $DAL, $FDX, $FLR, $J, $KBR, $LUV, $MTZ, $PWR, $UAL, $UNP, $UPS operate in infrastructure, transportation, or engineering sectors — but nothing in this bill creates a mechanism to contract or affect their businesses. The Presidential Memorandum on the Bridger Pipeline is entirely unrelated to this bill and should not be merged. Timeline: The bill was introduced 19 days ago and referred to committees. No hearings, markups, or votes have occurred. With the 119th Congress in its second session and no Senate companion, this bill faces very low odds of enactment in its current form.